Measured Wealth Private Client Group’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
VCM
VPM
SC
Measured Wealth Private Client Group's GMED Position: Q1 2026 in Review
Measured Wealth Private Client Group reduced its Globus Medical (GMED) stake by 15% in Q1 2026, selling an estimated $12K and leaving 749 shares worth $64.5K. The position accounts for 0.02% of the portfolio, ranked #266.
Measured Wealth Private Client Group first reported a position in GMED in Q3 2025 and has held it in 3 quarters since. The position peaked at $77.1K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Measured Wealth Private Client Group held 749 shares of Globus Medical worth $64.5K as of Q1 2026.
- Measured Wealth Private Client Group sold 134 Globus Medical shares in Q1 2026, an estimated $12K.
- Globus Medical made up 0.02% of Measured Wealth Private Client Group's portfolio in Q1 2026, its #266 holding.
- Measured Wealth Private Client Group first reported a position in Globus Medical in Q3 2025 and has held it in 3 quarters since.
- Measured Wealth Private Client Group's Globus Medical position peaked at $77.1K in Q4 2025.
- 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Measured Wealth Private Client Group's 13F filing for Q1 2026, filed 13 May 2026.